Luye Pharma Group Ltd.
Clinical trials sponsored by Luye Pharma Group Ltd., explained in plain language.
-
New depression pill takes first step in human safety trial
Disease control ENROLLING_BY_INVITATIONThis early-stage study tests a new tablet called LY03021 in 98 healthy adults aged 18 to 45. The main goal is to check the drug's safety and how the body processes it. This is a first step before testing the medicine in people with depression.
Phase: PHASE1 • Sponsor: Luye Pharma Group Ltd. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New IVF drug shows promise in early trial for better egg retrieval
Disease control OngoingThis study tests three different doses of a new drug called LY01021 in about 90 women undergoing IVF or ICSI. The goal is to find the best dose to control hormone levels and improve the number of eggs retrieved, fertilization rates, and pregnancy rates. Participants are married w…
Phase: PHASE2 • Sponsor: Luye Pharma Group Ltd. • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
Breakfast or not? study tests new pill for brain disorders
Knowledge-focused OngoingThis study looks at how taking a new extended-release tablet (LY03020) with or without food changes the way the body absorbs the drug. The medicine is being developed for schizophrenia and psychosis in Alzheimer's disease. Sixteen healthy adults will take the drug twice—once afte…
Phase: PHASE1 • Sponsor: Luye Pharma Group Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 07:59 UTC